ALLIANCEBERNSTEIN L.P. - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 131 filers reported holding INSMED INC in Q3 2018. The put-call ratio across all filers is 2.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of INSMED INC
ValueSharesWeighting
Q2 2024$166,982,425
+186.7%
2,492,275
+16.1%
0.06%
+176.2%
Q1 2024$58,233,975
-12.5%
2,146,479
-0.1%
0.02%
-19.2%
Q4 2023$66,563,483
+14.9%
2,147,902
-6.4%
0.03%
+4.0%
Q3 2023$57,943,599
+8.8%
2,294,796
-9.1%
0.02%
+13.6%
Q2 2023$53,269,967
+26.3%
2,524,643
+2.0%
0.02%
+22.2%
Q1 2023$42,188,315
-18.9%
2,474,388
-5.0%
0.02%
-21.7%
Q4 2022$52,031,596
-3.7%
2,604,184
+3.8%
0.02%
-11.5%
Q3 2022$54,034,000
-2.5%
2,508,562
-10.7%
0.03%
+4.0%
Q2 2022$55,418,000
-20.0%
2,810,224
-4.7%
0.02%
-7.4%
Q1 2022$69,303,000
-9.7%
2,949,049
+4.6%
0.03%0.0%
Q4 2021$76,790,000
+25.8%
2,819,013
+27.2%
0.03%
+12.5%
Q3 2021$61,023,000
+4.8%
2,215,802
+8.3%
0.02%
+4.3%
Q2 2021$58,239,000
-6.1%
2,046,355
+12.4%
0.02%
-14.8%
Q1 2021$61,997,000
+1.6%
1,820,242
-0.7%
0.03%
-6.9%
Q4 2020$61,017,000
-9.7%
1,832,886
-12.8%
0.03%
-19.4%
Q3 2020$67,535,000
+44.8%
2,101,261
+24.1%
0.04%
+33.3%
Q2 2020$46,626,000
+2247.7%
1,693,034
+1266.5%
0.03%
+2600.0%
Q1 2020$1,986,000
-29.9%
123,900
+4.4%
0.00%
-50.0%
Q4 2019$2,835,000
+50.3%
118,700
+11.0%
0.00%
+100.0%
Q3 2019$1,886,000
-59.0%
106,900
-40.6%
0.00%
-66.7%
Q2 2019$4,604,000
+16.3%
179,854
+32.1%
0.00%0.0%
Q1 2019$3,958,000
+168.3%
136,152
+21.1%
0.00%
+200.0%
Q4 2018$1,475,000
-36.0%
112,400
-1.4%
0.00%
-50.0%
Q3 2018$2,305,000
-14.5%
114,0000.0%0.00%0.0%
Q2 2018$2,696,000
-34.1%
114,000
-37.3%
0.00%
-33.3%
Q1 2018$4,094,000
-14.1%
181,800
+19.0%
0.00%0.0%
Q4 2017$4,764,000
+13.1%
152,800
+13.2%
0.00%0.0%
Q3 2017$4,213,000
+170.8%
135,000
+48.8%
0.00%
+200.0%
Q2 2017$1,556,000
+2.2%
90,700
+4.4%
0.00%0.0%
Q1 2017$1,522,000
+32.3%
86,9000.0%0.00%0.0%
Q4 2016$1,150,000
-8.9%
86,9000.0%0.00%0.0%
Q3 2016$1,262,000
+47.3%
86,9000.0%0.00%0.0%
Q2 2016$857,000
-22.2%
86,9000.0%0.00%0.0%
Q1 2016$1,101,000
-33.0%
86,900
-4.1%
0.00%0.0%
Q4 2015$1,644,000
-2.3%
90,6000.0%0.00%0.0%
Q3 2015$1,682,000
-24.1%
90,600
-0.1%
0.00%
-50.0%
Q2 2015$2,215,000
+76.9%
90,700
+50.7%
0.00%
+100.0%
Q1 2015$1,252,000
+34.5%
60,2000.0%0.00%0.0%
Q4 2014$931,000
+18.4%
60,2000.0%0.00%0.0%
Q3 2014$786,000
-34.7%
60,2000.0%0.00%0.0%
Q2 2014$1,203,000
+14.7%
60,200
+9.2%
0.00%0.0%
Q1 2014$1,049,000
+14.1%
55,105
+2.0%
0.00%0.0%
Q4 2013$919,000
+9.0%
54,0050.0%0.00%0.0%
Q3 2013$843,000
+301.4%
54,005
+207.1%
0.00%
Q2 2013$210,00017,5880.00%
Other shareholders
INSMED INC shareholders Q3 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,511,721$170,808,23415.39%
Octagon Capital Advisors LP 1,284,000$39,791,1606.37%
Cutter Capital Management, LP 413,499$12,814,3346.13%
Sio Capital Management, LLC 861,700$26,704,0836.08%
Deep Track Capital, LP 5,350,000$165,796,5005.54%
MPM BioImpact LLC 528,150$16,367,3693.83%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,684,487$83,192,2523.76%
Saltoro Capital, LP 36,550$1,132,6853.02%
Vestal Point Capital, LP 900,000$27,891,0002.96%
Novo Holdings A/S 1,339,304$41,505,0312.56%
View complete list of INSMED INC shareholders